BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825 AND Prognosis
3921 results:

  • 1. De-Escalated Therapy and Early Treatment of Recurrences in HPV-Associated head and neck cancer: The Potential for Biomarkers to Revolutionize Personalized Therapy.
    Yarbrough WG; Schrank TP; Burtness BA; Issaeva N
    Viruses; 2024 Mar; 16(4):. PubMed ID: 38675879
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. VDR is a potential prognostic biomarker and positively correlated with immune infiltration: a comprehensive pan-cancer analysis with experimental verification.
    Xia X; Xu F; Dai D; Xiong A; Sun R; Ling Y; Qiu L; Wang R; Ding Y; Lin M; Li H; Xie Z
    Biosci Rep; 2024 May; 44(5):. PubMed ID: 38639057
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Near-infrared imaging of head and neck squamous cell carcinoma using indocyanine green that targets the
    Yuan Y; Fan T; Wang J; Yuan Y; Tao X
    J Biomed Opt; 2024 Apr; 29(4):046002. PubMed ID: 38633382
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. HOXB9 promotes laryngeal squamous cell carcinoma progression by upregulating MMP12.
    Sun C; Deng H; Li Q; Wang P; Chen Y; Sun Y; Han C
    Funct Integr Genomics; 2024 Apr; 24(3):78. PubMed ID: 38632141
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Transcutaneous carbon dioxide suppresses skeletal muscle atrophy in a mouse model of oral squamous cell carcinoma.
    Sasaki A; Takeda D; Kawai H; Tadokoro Y; Murakami A; Yatagai N; Arimoto S; Nagatsuka H; Akashi M; Hasegawa T
    PLoS One; 2024; 19(4):e0302194. PubMed ID: 38630690
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Construction and validation of a folate metabolism-related gene signature for predicting prognosis in HNSCC.
    Wang L; He Y; Bai Y; Zhang S; Pang B; Chen A; Wu X
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):198. PubMed ID: 38625586
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Therapeutic Advances and Challenges for the Management of HPV-Associated Oropharyngeal cancer.
    Muniz IAF; Araujo M; Bouassaly J; Farshadi F; Atique M; Esfahani K; Bonan PRF; Hier M; Mascarella M; Mlynarek A; Alaoui-Jamali M; Silva SDD
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612819
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Identification of m6A/m5C-related lncRNA signature for prediction of prognosis and immunotherapy efficacy in esophageal squamous cell carcinoma.
    Wang J; Ren H; Xu C; Yu B; Cai Y; Wang J; Ni X
    Sci Rep; 2024 Apr; 14(1):8238. PubMed ID: 38589454
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Survival benefits of human papillomavirus 16 infection in patients with esophageal squamous cell carcinoma undergoing chemoradiotherapy: A retrospective cohort study.
    Qu F; Ji C; Wang Y; Zhu R; Hu W; Liu S; Zhao X; Li J; Miao G; Zhang M; Zhang X; Sun Y
    J Med Virol; 2024 Apr; 96(4):e29592. PubMed ID: 38587184
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Evaluation of Some Prognostic Biomarkers in Human Papillomavirus-Related Multiphenotypic Sinonasal Carcinoma.
    Alabiad MA; Said WMM; Adim AMA; Alorini M; Shalaby AM; Samy W; Elshorbagy S; Mandour D; Saber IM; Yahia AIO; Khairy DA
    Iran J Med Sci; 2024 Mar; 49(3):156-166. PubMed ID: 38584650
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. HSP27 promotes vasculogenic mimicry formation in human salivary adenoid cystic carcinoma via the AKT-MMP-2/9 pathway.
    Xu ZY; Han J; Yang K; Zhang GM; Jiao MN; Liang SX; Yan YB; Chen W
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 May; 137(5):515-528. PubMed ID: 38553306
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Immune microenvironment of human papillomavirus-positive head and neck squamous cell carcinoma.
    Zhu D; He X; Li Y; Li G; Chen M
    Sci Prog; 2024; 107(1):368504241237888. PubMed ID: 38545800
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Identification of Down-Expressed CRNN Associated with cancer Progression and Poor prognosis in Laryngeal Squamous Cell Carcinoma.
    Hong F; Wan X; Bai Y
    Front Biosci (Landmark Ed); 2024 Mar; 29(3):125. PubMed ID: 38538265
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Utilizing the AJCC 8
    Kim SI; Lee JW; Eun YG; Lee YC
    Anticancer Res; 2024 Apr; 44(4):1703-1710. PubMed ID: 38538003
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Unlocking the Therapeutic Potential of LncRNA
    Liu FL; Zhang ZC; Zhou SL; Liu XL; Xu W
    Discov Med; 2024 Mar; 36(182):546-558. PubMed ID: 38531795
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Treatments on the horizon for locally advanced basal cell carcinoma.
    Idriss MH; Stull CM; Migden MR
    Cancer Lett; 2024 May; 589():216821. PubMed ID: 38521198
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Advances in testing for human papillomavirus -mediated head and neck cancer.
    Mehanna H; Alemany L; von Buchwald C
    Curr Opin Oncol; 2024 May; 36(3):143-146. PubMed ID: 38506408
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Supramolecular nanodrug targeting CDK4/6 overcomes BAG1 mediated cisplatin resistance in oral squamous cell carcinoma.
    Zhao B; Qin X; Fu R; Yang M; Hu X; Zhao S; Cui Y; Guo Q; Zhou W
    J Control Release; 2024 Apr; 368():623-636. PubMed ID: 38479445
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Brain metastases in patients with salivary duct carcinoma: A retrospective study.
    Fushimi C; Takahashi H; Kawakita D; Kano S; Tsukahara K; Ozawa H; Okami K; Sakai A; Yamazaki K; Okada T; Hanazawa T; Sato Y; Imanishi Y; Shimizu A; Matsuki T; Nagao T; Tada Y
    Cancer Med; 2024 Mar; 13(5):e7037. PubMed ID: 38477487
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Tetraspanin CD82 Correlates with and May Regulate S100A7 Expression in Oral cancer.
    Reddi KK; Zhang W; Shahrabi-Farahani S; Anderson KM; Liu M; Kakhniashvili D; Wang X; Zhang YH
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473906
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 197.